Alogliptin Benzoate/Metformin Hydrochloride |
|
Approved |
Takeda Pharmaceutical Co Ltd |
Kazano, Inisync, Vipdomet |
Japan |
Diabetes Mellitus, Type 2 |
s:6:"Takeda"; |
2013-01-25 |
Diabetes Mellitus, Type 2 |
Details
|
Alogliptin Benzoate/Pioglitazone Hydrochloride |
SYR-322-4833 BL |
Approved |
Takeda Pharmaceutical Co Ltd |
Oseni, Liovel, Incresync, Nesinaact |
EU |
Diabetes Mellitus, Type 2 |
s:17:"Takeda Pharma A/S"; |
2011-07-01 |
Diabetes Mellitus, Type 2 |
Details
|
Anagliptin |
SK-0403; CWP-0403 |
Approved |
Sanwa Kagaku Kenkyusho Co Ltd |
Suiny, Beskoa |
Japan |
Diabetes Mellitus, Type 2 |
s:4:"null"; |
2012-09-28 |
Diabetes Mellitus, Type 2 |
Details
|
Empagliflozin/Linagliptin/Metformin |
|
Approved |
Boehringer Ingelheim Gmbh, Eli Lilly And Company |
Trijardy XR |
United States |
Diabetes Mellitus, Type 2 |
s:25:"Boehringer Ingelheim Gmbh"; |
2020-01-27 |
Diabetes Mellitus, Type 2 |
Details
|
Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride |
|
Approved |
Astrazeneca Plc |
Qtern |
United States |
Diabetes Mellitus, Type 2 |
s:14:"Astrazeneca Ab"; |
2016-07-15 |
Diabetes Mellitus, Type 2 |
Details
|
Linagliptin/Metformin Hydrochloride |
|
Approved |
Boehringer Ingelheim Gmbh |
欧双宁, Jentadueto, Trajenta Duo, Jentadueto Xr |
Mainland China |
Diabetes Mellitus, Type 2 |
s:35:"Boehringer Ingelheim (Schweiz) Gmbh"; |
2012-01-30 |
Diabetes Mellitus, Type 2 |
Details
|
Gemigliptin L-tartrate Sesquihydrate/Metformin Hydrochloride |
|
Approved |
Lg Life Sciences Ltd |
ZemiMet SR |
South Korea |
Diabetes Mellitus, Type 2 |
s:20:"Lg Life Sciences Ltd"; |
2015-01-01 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin Hydrochloride |
|
Approved |
|
|
EU |
|
s:21:"Laboratorios Alter Sa"; |
2018-11-27 |
|
Details
|
Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride |
|
Approved |
Handok Inc |
Tenelia M SR |
South Korea |
Diabetes Mellitus, Type 2 |
s:10:"Handok Inc"; |
2015-11-03 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin/Ertugliflozin |
|
Approved |
Pfizer Pharmaceuticals Ltd (China) |
Steglujan |
EU |
Diabetes Mellitus, Type 2 |
s:22:"Merck Sharp & Dohme Bv"; |
2017-12-19 |
Diabetes Mellitus, Type 2 |
Details
|
Trelagliptin Succinate |
SYR-111472 succinate; SYR-111472; TAK-472; SYR-472 |
Approved |
Takeda Pharmaceutical Co Ltd |
Zafatek |
Japan |
Diabetes Mellitus, Type 2 |
s:6:"Takeda"; |
2015-03-26 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Linagliptin/Empagliflozin |
BI 10773/BI 1356; BI 1356/BI 10773; BI 10773/linagliptin; Linagliptin/BI 10773; BI 1356/empagliflozin; Empagliflozin/BI 1356 |
Approved |
C.H. Boehringer Sohn Ag & Co. Kg |
Glyxambi, Tradiance |
United States |
Cardiovascular Diseases |
s:25:"Boehringer Ingelheim Gmbh"; |
2015-01-30 |
Diabetes Mellitus, Type 2; Cardiovascular Diseases |
Details
|
Dapagliflozin/Saxagliptin/Metformin hydrochloride |
|
Approved |
Astrazeneca Pharmaceutical Co Ltd |
Qtrilmet, Qternmet XR |
United States |
Diabetes Mellitus, Type 2 |
s:14:"Astrazeneca Ab"; |
2019-05-02 |
Diabetes Mellitus, Type 2 |
Details
|
Anagliptin/Metformin Hydrochloride |
SK-1501 |
Approved |
Sanwa Kagaku Kenkyusho Co Ltd, Suzuken |
Metoana |
Japan |
Diabetes Mellitus, Type 2 |
s:4:"null"; |
2018-09-21 |
Diabetes Mellitus, Type 2 |
Details
|
Teneligliptin Hydrobromide Hydrate/Canagliflozin Hemihydrate |
|
Approved |
Mitsubishi Tanabe Pharma Corp, Daiichi Sankyo Co Ltd |
Canalia |
Japan |
Diabetes Mellitus, Type 2 |
s:47:"Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma"; |
2017-07-03 |
Diabetes Mellitus, Type 2 |
Details
|
Metformin Hydrochloride/Sitagliptin Hydrochloride |
|
Approved |
Sandoz Bv |
|
欧洲联盟 |
|
s:9:"Sandoz Bv"; |
2019-12-10 |
|
Details
|
Sitagliptin Tartrate |
|
Approved |
Heumann Pharma Gmbh & Co. Generica Kg |
Sitagliptin Heumann 25 mg Filmtabletten |
欧洲联盟 |
|
s:37:"Heumann Pharma Gmbh & Co. Generica Kg"; |
2020-12-14 |
|
Details
|
Evogliptin Tartrate/Metformin Hydrochloride |
DA-1229_01 |
Approved |
Dong-A Pharmaceutical Co Ltd |
Sugamet XR |
South Korea |
Diabetes Mellitus, Type 2 |
s:28:"Dong-A Pharmaceutical Co Ltd"; |
2015-12-01 |
Diabetes Mellitus, Type 2 |
Details
|
Saxagliptin Hydrochloride/Metformin Hydrochloride |
|
Approved |
Astrazeneca Pharmaceutical Co Ltd |
安立格, Komboglyze, Kombiglyze Xr |
Mainland China |
Diabetes Mellitus, Type 2 |
s:14:"Astrazeneca Ab"; |
2010-11-05 |
Diabetes Mellitus, Type 2 |
Details
|
Vildagliptin |
LAF-237; DSP-7238; LAF-237A; NVP-LAF-237 |
Approved |
Novartis Pharma Ag |
佳维乐, Equa, Jalra, Galvus, Gliptus, Xiliarx |
Mainland China |
Diabetes Mellitus, Type 2 |
s:22:"Novartis Europharm Ltd"; |
2007-09-25 |
Prediabetic State; Diabetes Mellitus, Type 2; Renal Insufficiency; Kidney Diseases; Diabetes Mellitus |
Details
|
Omarigliptin |
MK-3102 |
Approved |
Merck & Co Inc |
Marizev |
Japan |
Diabetes Mellitus, Type 2 |
s:24:"Merck Sharp & Dohme Corp"; |
2015-09-28 |
Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic |
Details
|
Sitagliptin Phosphate Monohydrate |
MK-431; MK-0431; ONO-5435; ONO-5435A; L-000224715 |
Approved |
Merck Sharp & Dohme Corp |
捷诺维, Glactiv, Januvia, Tesavel, Xelevia, Ristaben |
Japan |
Diabetes Mellitus, Type 2 |
s:51:"Ono Pharmaceutical Co Ltd, Merck Sharp & Dohme Corp"; |
2006-10-16 |
Diabetes Mellitus, Type 2; Renal Insufficiency; Glucose Intolerance; Dyslipidemias; Hepatic Insufficiency; Kidney Failure, Chronic; Diabetes Mellitus |
Details
|
Sitagliptin Phosphate/Metformin Hydrochloride |
|
Approved |
Merck & Co Inc |
Janumet, Velmetia |
Mainland China |
Diabetes Mellitus, Type 2 |
s:30:"Msd Pharma (Singapore) Pte Ltd"; |
2007-03-30 |
Diabetes Mellitus, Type 2 |
Details
|
Vildagliptin/Metformin Hydrochloride |
LMF-237 |
Approved |
Novartis Pharma Ag |
宜合瑞, EquMet, Eucreas, Icandra, Zomarist |
Japan |
Diabetes Mellitus, Type 2 |
s:18:"Novartis Pharma Ag"; |
2007-11-14 |
Diabetes Mellitus, Type 2 |
Details
|
Gemigliptin L-tartrate Sesquihydrate |
LC-150444; LC-15-0444 |
Approved |
Lg Life Sciences |
Gemiglo, Zemiglo |
South Korea |
Diabetes Mellitus, Type 2 |
s:20:"Lg Life Sciences Ltd"; |
2012-06-27 |
Diabetes Mellitus, Type 2; Hepatic Insufficiency |
Details
|
Linagliptin |
BI-1356; BI-1356-BS |
Approved |
Boehringer Ingelheim Gmbh |
欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, Tradjenta |
Mainland China |
Diabetes Mellitus, Type 2 |
s:39:"Boehringer Ingelheim International Gmbh"; |
2011-05-02 |
Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency; Carcinoma, Transitional Cell; Hypertension; Hepatic Insufficiency |
Details
|
Alogliptin Benzoate |
SYR-322; TAK-322 |
Approved |
Takeda |
尼欣那, Nesina, Vipidia |
EU |
Diabetes Mellitus, Type 2 |
s:17:"Takeda Pharma A/S"; |
2010-04-06 |
Diabetes Mellitus, Type 2; Acute Coronary Syndrome; Diabetes Mellitus |
Details
|
Evogliptin |
DA-1229 |
Approved |
Dong-A Pharmaceutical Co Ltd |
Suganon, Sugarnon |
South Korea |
Diabetes Mellitus, Type 2 |
s:28:"Dong-A Pharmaceutical Co Ltd"; |
2015-10-02 |
Diabetes Mellitus, Type 2; Kidney Diseases; Aortic valve diseases; Liver Diseases |
Details
|
Teneligliptin Hydrobromide Hydrate |
MP-513 |
Approved |
Mitsubishi Tanabe Pharma |
Tenelia, Tenglyn |
Japan |
Diabetes Mellitus, Type 2 |
s:47:"Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma"; |
2012-06-29 |
Diabetes Mellitus, Type 2 |
Details
|
Saxagliptin Hydrate |
OPC-262; BMS-477118; BMS-477118-11 |
Approved |
Bristol-Myers Squibb Company |
安立泽, Onglyza |
Japan |
Diabetes Mellitus, Type 2 |
s:24:"Kyowa Hakko Kirin Co Ltd"; |
2009-07-31 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline |
MK-0431J |
Approved |
Merck & Co Inc, Astellas Pharma Inc |
Sujanu |
Japan |
Diabetes Mellitus, Type 2 |
s:4:"null"; |
2018-03-23 |
Diabetes Mellitus, Type 2 |
Details
|